FDA's top drug regulator resigns amid probe into 'serious personal conduct' allegations
The head of the FDA's drug center has abruptly resigned amid a federal investigation into 'serious concerns' about his personal conduct. The resignation comes as officials reviewed allegations against him.
The head of the FDA's drug center has resigned after federal officials launched an investigation into 'serious concerns' surrounding his personal conduct, citing an abrupt and unexplained departure from work. The resignation comes as a surprise to industry insiders and regulators, who are now focused on determining the cause of the sudden move. An FDA spokesperson confirmed that Dr. Sharp resigned due to personal reasons but declined to provide further details. The agency is reviewing internal procedures to ensure transparency and accountability.
